Clinical Trial

Optimization of Cardiac Imaging in Women With Early-Stage Breast Cancer

Name: Optimization of Cardiac Imaging in Women With Early-Stage Breast Cancer — clinical trial record (NCT07630402)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: POCEB

Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of this study is to determine whether a personalized, risk-stratified surveillance strategy can safely reduce unnecessary cardiac imaging while preserving early detection of treatment-related cardiotoxicity in women with breast cancer (BC) receiving HER2-targeted therapy (HER2-TT).

Trial Details

NCT Number	NCT07630402
Lead Sponsor	University of Rochester
Conditions	Breast Cancer With Low to Intermediate HER2 Expression
Enrollment	20 participants
Start Date	2025-11-17
Primary Completion	2031-06-30 (estimated)
Study Completion	2031-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-05